SIGMAR1 and neoplasm: As a result, the overexpression of SIGMAR1 was observed in tumors vs. adjacent non-tumor tissues in the TCGA data (p < 0.001) and confirmed in our in-house cohort study (p < 0.016) (Figure 1A,B).